Clinical Trials Details

A051701 (Lymphoma)

A Randomized Phase II/III Study of Venetoclax (ABT199) plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas

Objective

DHL was temporarily suspended on Sept. 28, 2020.

Clinical Trial Categories

  • Cancers and Other Neoplasms